However, obesity has been established as an independent risk factor for developing post-ERCP pancreatitis, potentially due to a low-grade chronic inflammatory state related to a decreased level of adiponectin, an anti-inflammatory adipokine [14]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.